1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Lymphocyte Count: new trials by email Literature Review of Lymphocyte Count trials Research Report on Lymphocyte Count
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies Rituximab, Cyclophosphamide, Fludarabine - Leukemia, Lymphoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 4 | 2007-05-01 | 2011-12-19 |
| Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3 Lymphocytes, Activated - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2021-11-03 |
AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · Graft vs Host Disease (1) · HIV Infections (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Neoplasms, Plasma Cell (1)
M.D. Anderson Cancer Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2)
D Stein (1) · H Standiford (1) · J Lieberman (1) · Richard E. Champlin, MD (1)